A clinical trial of anAyurvedic regime in Covid-19 positive patients has shown encouraging results. The study also proves that Ayurveda is low-risk and cost-effective
A clinical study of an Ayurveda regimen as an add-on in Covid-19 patients by four experts —Pankaj Wanjarkhedkar and Girish Sarade of Department of Ayurveda & Integrative Medicine, Bharat Purandare of Department of Infectious Diseases, and Dhananjay Kelkar of Deenanath Mangeshkar Hospital & Research Centre–has proved that Ayurveda therapy is effective in treating Covid-19 patients.
According to the findings of the study, published in the Journal of Ayurveda and Integrative Medicine, there was “early clinical improvement in breathlessness” in patients. “Ageusia reduced early withadd-on Ayurveda regimen. The median duration of hospital staywas reduced,” states the report.
For the study, experts used a combination of Ayurvedic medications as an add-on in Covid-19 positive patientsin a dedicated Covidhospital. The objective of the study was to evaluate the additional benefit of anAyurvedic regime in Covidpositive patients on the basis of rate of clinical improvement. “The Ayurvedic formulation was administered as an add-on to Standard of Care (SoC) in patients with mild to moderatesymptoms, in this prospective, open-label, comparative study. Control group received SoC only. Patientsreceiving Dasamoolkaduthrayam Kashaya and GuluchyadiKwatham in tablet form in addition to the SoCshowed a faster recovery from breathlessness with reduced ageusia. Patients on the treatment groupcould be discharged earlier than those from the control group. Addition of Dasamoolkaduthrayam Kashaya and Guluchyadi Kwatham to SoC appeared to accelerate recovery of patients hospitalised for Covid -19 infection, in terms of reduction of symptoms and duration of hospital stay,” says the report.
According to the report, the study was conducted after four months of Covid-19 pandemicalert; no specific antiviral treatment/vaccine had been recommended or made available by then. “The study was intended toexplore the potential from Ayurveda with evidence over justexperience. This study was initiated after extensive discussionsamong the physicians from the departments of infectious disease,intensive care and Ayurveda of this institute. Covid-19 patientswere presented with low grade fever, dry cough, muscle pain, ormalaise. In some patients sore throat and headache were observed.Cough and shortness of breath were present without signs of severe pneumonia at presentation. Ageusia was observed predominantly; anosmia in few. An European study mentioned thatin mild to moderate Covid-19 category, 88% patient had the gustatory dysfunction. It was observed that dry cough wasoften associated with difficulty in breathing.”
Moreover, the study has found that add-on Ayurveda regimen was low risk and highly cost effective as it reduced hospital stay. No adverse effects observed in study group, stated the report.